Inhibrx Biosciences, Inc. INBX Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s other income, net (note 6)?
- Inhibrx Biosciences, Inc. (INBX) reported other income, net (note 6) of -$12K in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s other income, net (note 6) changed year-over-year?
- Inhibrx Biosciences, Inc.'s other income, net (note 6) increased by 76.0% year-over-year, from -$50K to -$12K.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s other income, net (note 6)?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s other income, net (note 6) has grown at a -19.0% compound annual growth rate (CAGR), from -$580K to -$381K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.